Olivier Mauroy-Bressier was appointed as Chief Financial Officer (CFO), Pharmaceuticals in October 2022.
Olivier joined Bayer through the Aventis Crop Science acquisition in 2001, where he led Finance for the Central America Cluster.

From 2002 through 2008, he held increasing responsibilities in the areas of Finance, Strategic Planning, Mergers & Acquisitions and Transfer Price Office for Bayer Crop Science in the US and the headquarters in Germany, before becoming CFO for Bayer in France in 2009.

Between 2014 and 2016, Olivier headed the Global Controlling and Business Analytics organization for Bayer Consumer Care in the US before relocating to Basel, Switzerland to lead the establishment of Consumer Health division as CFO, coordinating and overseeing the subsequent turn-around of the business until end of 2019.

Before taking his current role, Olivier served as Head of Internal Audit & Risk Management for the Bayer Group, dedicated to safeguarding and strengthening Bayer’s license to operate.
Olivier holds a master’s degree in Corporate Finance from EDHEC Business School, France.